Executive Intelligence
Life Sciences Reports
Regulatory, funding, leadership, market and commercial updates selected for life-science executives.
Notice: Medicines: terminated and cancelled manufacturing and wholesale dealer licences
UK companies who have their licence to manufacture or wholesale medicines terminated and cancelled.
Read full reportDecision: Human medicines: register of licensed wholesale distribution sites
Department of Health and Social Care and MHRA register of licensed wholesale distribution sites (human).
Read full reportField Safety Notices: 3 to 7 August 2026
List of Field Safety Notices from 3 to 7 August 2026.
Read full reportFind product information about medicines
How to get information including patient information leaflets (PILs), details on how the medicine can be used (SPCs) and scientific reports (PARs).
Read full reportMHRA advises quarantine of medical devices supplied without appropriate conformity markings
The MHRA has become aware of a number of medical devices being supplied on the UK market that do not comply with the requirements of the UK Medical Device Regulations 2002 (UK MDR 2002) or with the EU Medical Devices Regulation (EU)…
Read full reportDevices supplied without valid UKCA/CE conformity markings or certification: remove from use and place in quarantine (DSI/2026/007)
The MHRA has become aware of a number of medical devices being supplied on the UK market that do not comply with the requirements of the UK Medical Device Regulations 2002 (UK MDR 2002) or with the EU Medical Devices Regulation (EU)…
Read full reportUK first in Europe to authorise orforglipron for weight management and type 2 diabetes
As with all GLP-1 receptor agonists, the MHRA will keep the safety and effectiveness of orforglipron under close review.
Read full reportGood laboratory practice (GLP) for safety tests on chemicals
Keep up to date with the latest information from the UK GLP monitoring authority.
Read full reportTaking medication this summer? What you need to know about sun and heat exposure
Some medicines can make you more sensitive to the sun or increase the risk of dehydration without you realising it. The MHRA is encouraging people to know the risks and stay protected this summer.
Read full reportGuidance: Medicines that you cannot export from the UK or hoard
Sets out medicines that cannot be exported from the UK or hoarded because they are needed for UK patients.
Read full reportFDA Issues Emergency Use Authorization for Drug to Prevent New World Screwworm in Multiple Species, Including Sheep, Cattle, Goats, and Swine
FDA today issued an Emergency Use Authorization (EUA) for CLiK Extra (dicyclanil topical suspension) wound spray for application on or around wounds for the prevention of New World screwworm (NWS) infestations (myiasis).
Read full reportFDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant Advanced Melanoma
The U.S. Food and Drug Administration today granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg), a genetically modified oncolytic viral therapy for the treatment of advanced, refractory melanoma.
Read full reportMHRA approves remibrutinib for adults with chronic spontaneous urticaria
As with any medicinal product, the MHRA will keep the safety and effectiveness of remibrutinib under close review.
Read full reportBelzer UW® Cold Storage Solution and Belzer MPS® (UW Machine Perfusion Solution): manufactured by Carnamedica (UKRP: Bridge to Life): Updated advice on the contamination of fluid DSI/2026/006 (update to DSI/2023/005)
The MHRA is providing an update on defects previously identified with Belzer solutions for the preservation of donated organs. This DSI replaces advice in DSI/2023/005.
Read full reportFDA Approves First Drug to Treat the Full Range of Narcolepsy Type 1 Symptoms
The FDA approved Orzeyful (oveporexton) tablets for the treatment of narcolepsy type 1 in adults.
Read full reportDecision: Advertising investigations: July 2026
Decisions made by MHRA on adverts reported to have breached the legislation on advertising medicines.
Read full reportGuidance: Innovative Licensing and Access Pathway (ILAP)
The Innovative Licensing and Access Pathway (ILAP) is focused on getting the most transformative new medicines to patients in the UK health system more quickly.
Read full reportField Safety Notices: 27 to 31 July 2026
List of Field Safety Notices from 27 to 31 July 2026
Read full reportDräger Atlan Anaesthesia workstations: risk of ventilator failure (DSI/2026/005)
In April 2026, Dräger issued a follow-up Field Safety Notice expanding the number of Atlan Anaesthesia workstation devices affected by a manufacturing defect that may result in mechanical ventilation failure.
Read full reportThe Innovative Licensing and Access Pathway grants Innovation Passports to investigational products for cancer and dementia
Innovative investigational products for liver cancer and dementia recognised through the Innovative Licensing and Access Pathway ahead of next application round opening.
Read full reportDecision: Human medicines: register of electronic export certificates
Department of Health and Social Care and MHRA register of electronic export certificates (human).
Read full reportClinical trials for medicines: MHRA phase I accreditation scheme
How to join the phase I accreditation scheme.
Read full reportNew leadership team appointments
EMA’s Head of the Stakeholders…, A new Head of the Veterinary…, Ivo Claassen joined EMA in 2018. Among many career highlights, Ivo and his team worked with the veterinary medicines network on the successful implementation of the 2019…
Read full reportMHRA Safety Roundup: July 2026
Summary of the latest safety advice for medicines and medical device users
Read full report